Pharmaceuticals News

미국 캘리포니아주 랜초 코르도바, March 20, 2026 (GLOBE NEWSWIRE) -- SK 팜테코 (SK pharmteco)가 자사의 바이럴 벡터 사업 내 전략적 이니셔티브를 지원하기 위한 대규모 자금 투자를 단행한다고 오늘 발표하며, 소분자, 펩타이드, 바이럴 벡터 등 세 가지 사업 부문에 걸친 장기 성장 전략을 재확인했다. SK...

RANCHO CORDOVA, Kalifornien, March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco gab heute eine bedeutende Finanzierungszusage zur Unterstützung strategischer Initiativen im Bereich seines...

RANCHO CORDOVA, Californie, 19 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un engagement de financement significatif visant à soutenir des initiatives stratégiques au sein de...

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

Calroy releases new research explaining the role of the endothelial glycocalyx in circulation and why standard cardiovascular tests miss microvascular func

US FDA has approved Wegovy® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term.

Company Announcement At Genmab A/S’ Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approvedDischarge was given to the Board of Directors and the Executive Management...

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

Conference call will be held today, Thursday, March 19 at 10:00 am ET Woburn, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company...

Pelareorep treatment drives coordinated immune activation and tertiary lymphoid structure formation  Translational data suggest potential to boost response to immunotherapy and targeted therapy in...